The impact of acute rosiglitazone on insulin pharmacokinetics at the blood-brain barrier.
Demi C GalindoWilliam A BanksElizabeth M RheaPublished in: Endocrinology, diabetes & metabolism (2020)
Acute RSG treatment does not alter insulin BBB transport in healthy mice but can restore insulin receptor binding at the BBB in an insulin-resistant state.